DermSurgery Associates Blog

DermSurgery Associates

What You Need to Know About Skin Cancer and Mohs Surgery

Is it time for a professional cancer screening? In the United States in 2013, an estimated 1,660,290 new cases of cancer were diagnosed. The American Cancer Society estimates that 580,350 of these cases will end in death. The society projects that melanoma skin cancer accounted for 76,690 of the newly diagnosed cancer cases, with 9,480 …

Read More
DermSurgery Associates

Thermage treatment from DermSurgery Associates of Houston

The proven way to combat skin wrinkles and other signs of aging - As people get older, they begin seeing the effects of chronological aging on their bodies. Wrinkles are forming around the eyes, the skin around the neck is losing its elasticity, odd budges and wrinkles are appearing here and there.  Nobody enjoys seeing …

Read More
DermSurgery Associates

XTRAC – Take Control of your Psoriasis!

Using a carefully focused beam of laser light delivered through a sophisticated liquid light guide delivery system, the XTRAC system is designed to clear unsightly psoriatic skin plaques quickly and effectively. Because it concentrates light on active lesions, XTRAC allows your health care technician to deliver the high therapeutic doses necessary for rapid clearing without …

Read More
DermSurgery Associates

New Survey Results from the American Society for Dermatologic Surgery Demonstrate Broad Scope of Practice for Dermatologic Surgeons

From the American Society for Dermatological Surgery - New statistics released today by the American Society for Dermatologic Surgery (ASDS) demonstrate the broad scope of practice and breadth of experience of dermatologic surgeons. In addition to more than 2.6 million skin cancer treatments in 2011, ASDS members continue to be a leading provider of a …

Read More
DermSurgery Associates

Local physician involved in clinical trials of Erivedge™ (Vismodegib), the First Medicine for Adults with Advanced Basal Cell Carcinoma

Houston, TX - February 3, 2012 - Genentech announced that Erivedge ™ (vismodegib) capsule was approved by the U.S. Food and Drug Administration (FDA) for the treatment of adults with basal cell carcinoma (BCC, a type of skin cancer.) Erivedge™ was approved on January 30, 2012. Dr. Leonard H. Goldberg, a Houston Dermatological surgeon, has …

Read More
DermSurgery Associates

Important New Developments in actinic keratoses and basal cell carcinoma!

New treatments have been approved for for both actinic keratoses and basal cell carcinoma.  From Skin and Allergy News: Actinic Keratoses "The Food and Drug Administration approved two strengths of ingenol mebutate gel for the treatment of actinic keratoses Jan. 23. The 0.015% formulation of ingenol mebutate gel (Picato) was approved for the treatment of …

Read More